Diabetes Care: Improved blood sugar control may also help COVID-19 results

, June 18, 2020 /
PRNewswire/ -- Insulin infusions help meet blood sugar targets and may reduce the risk of poor prognosis in patients with high blood sugar and COVID-19, according to a study published May 19 in the journalDiabetes
Care, Ph.D., and colleagues from the University of Campania in Italy studied the effects of optimal blood sugar control on patients with high blood sugar and COVID-19In 59 cases of COVID-19 patients admitted to hospital, for moderate symptomatic diseases, blood sugar was 7.77 mmol/L at the time of admission (of which 34 cases of normal blood sugar and 25 cases of high blood sugar)Photo Source: The researchers found that the average blood sugar of patients who did not receive insulin infusions was 10.65 mmol/L during hospitalization, while the average blood sugar of patients in the insulin infusion group was 7.69 mmol/L during hospitalizationIn the high blood glucose group, at baseline, the levels of interleukin-6 and D-dipolymers were significantly higher than in the normal blood glucose groupNeuleuke interlemia levels of interleukin-6 and D-dipolymers continued to rise during hospitalization in patients with high blood sugar, although all patients received standard treatment for COVID-19 infectionBoth patients with high blood sugar and patients withdiabeteshad a higher risk of serious disease than patients with non-
diabetes
and patients with normal blood sugarPatients with hyperglycemia who did not inject insulin had a lower risk of serious illness than those with hyperglycemia who did not inject insulin"Since inflammatory cytokines and coagulation have been shown to lead to adverse prognosis in patients with COVID-19, we speculate that optimizing blood sugar control may reduce the risk of progression of infectious diseases by reducing interleukin-6 and D-dipolymer levels,"the authors wrote(BioValleyBioon.com)References: celestino Sardu et al.
Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?Diabetes Care 2020 May; dc200723https://doi.org/10.2337/dc20-0723